Pluri (PLUR) Receivables - Other (2011 - 2024)
Pluri (PLUR) reported Receivables - Other of $10000.0 for Q2 2024, down 73.68% year-over-year from $38000.0 in Q3 2023, and down 73.68% quarter-over-quarter from $38000.0 in Q2 2023.
Pluri (PLUR) Receivables - Other (2011 - 2024) Analysis & Trends
Pluri (PLUR) has 13 years of Receivables - Other data on file, last reported at $10000.0 in Q2 2024.
- Receivables - Other for Q2 2024 came in at $10000.0, down 73.68% year-over-year; the trailing twelve-month figure through Jun 2024 was $10000.0 (down 73.68% YoY), and the FY2024 annual result was $10000.0, down 73.68% from the prior year.
- Receivables - Other slipped to $10000.0 in Q2 2024 per PLUR's latest filing, from $38000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $52000.0 in Q2 2021 and troughed at $10000.0 in Q2 2024.
- A 5-year average of $41818.2 and a median of $52000.0 in 2021 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2021 and 2024: Receivables - Other jumped 100.0% in 2021, then slumped 73.68% in 2024.
- A 5-year view of Receivables - Other shows it stood at $26000.0 in 2020, then jumped by 100.0% to $52000.0 in 2021, then changed by 0.0% to $52000.0 in 2022, then slipped by 26.92% to $38000.0 in 2023, then slumped by 73.68% to $10000.0 in 2024.
- Business Quant data shows PLUR's Receivables - Other at $10000.0 in Q2 2024, $38000.0 in Q2 2023, and $52000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |